Tirzepatide savings: $145 PPPM; HSA account growth; NSA IDR findings

HTN Daily Brief: 08/27/2026

Aug 27, 2026

Martin Cech & Kevin O'Leary

Keep Reading

Sword to buy Headspace; Wildflower is EBITDA and GAAP profitable; Oura IPO scuttlebutt

Aug 26, 2026

•

3 min read

Sword to buy Headspace; Wildflower is EBITDA and GAAP profitable; Oura IPO scuttlebutt

HTN Daily Brief: 08/26/2026

Martin Cech, Kevin O'Leary

Devoted's $25b valuation; Highmark's health insurance tailwinds; Disney cuts benefits for spouses

Aug 25, 2026

•

3 min read

Devoted's $25b valuation; Highmark's health insurance tailwinds; Disney cuts benefits for spouses

HTN Daily Brief: 08/24/2026

Martin Cech, Kevin O'Leary